Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 3, 2015, Pages

  Ohlsson, Arne ^a   Shah, Prakeshkumar S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; IBUPROFEN; INDOMETACIN; OXYGEN; PARACETAMOL; PLACEBO; PROSTAGLANDIN SYNTHASE INHIBITOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALL CAUSE MORTALITY; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN HEMORRHAGE; CHINA; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; ECHOCARDIOGRAPHY; ENCEPHALOMALACIA; EVIDENCE BASED MEDICINE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GESTATIONAL AGE; HEART SURGERY; HUMAN; HYPERBILIRUBINEMIA; INFANT; INFANT MORTALITY; INTESTINE PERFORATION; LASER SURGERY; LENGTH OF STAY; LOW BIRTH WEIGHT; LUNG DYSPLASIA; LUNG HEMORRHAGE; NECROTIZING ENTEROCOLITIS; NEWBORN MORTALITY; OLIGURIA; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROLENTAL FIBROPLASIA; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SEPSIS; SYSTEMATIC REVIEW; TREATMENT DURATION; TURKEY (REPUBLIC); DUCTUS ARTERIOSUS, PATENT; META ANALYSIS; NEWBORN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); UTILIZATION;

ACETAMINOPHEN; ADMINISTRATION, ORAL; DUCTUS ARTERIOSUS, PATENT; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; OXYGEN INHALATION THERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84942557025     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010061.pub2     Document Type: Review

References (53)

1. Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: A randomized controlled trial. PLos ONE 2013;8(11):e77888.
2. Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: A randomized controlled trial. The Journal of Pediatrics 2013;13:S0022-3476(13)01394-2. doi: 10.1016/j.jpeds.2013.11.008. [Epub ahead of print].
3. Zarkesh MR, Nili F, Akbari Asbagh P, Nayeri FS, Naeem A. Prophylactic treatment with oral paracetamol for patent ductus arteriosus in preterm infants admitted in NICU Vali-Asr Hospital in 2012. Iranian Journal of Pediatrics 2013;23:S54-5.
4. NCT01291654. Paracetamol in the treatment of patent ductus arteriosus in the premature neonate. Clinicaltrials.gov/show/NCT01291654 (December 2013).
5. NCT01938261. The preterm infants' paracetamol study (PreParaS). Clinicaltrials.gov/show/NCT01938261 (December 2013).
6. NCT02002741. Adding paracetamol to ibuprofen for treatment of patent ductus arteriosus in preterm infants. ClinicalTrials.gov/show/NCT02002741 (December 2013).
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th Edition. Arlington, VA: American Psychiatric Association, 2013.
8. Arana A, Morton NS, Hansen TG. Treatment with paracetamol in infants. Acta Anaesthesiologica Scandinavica 2001;45:20-9. [PUBMED: 11152028 ]
9. Bartocci M, Lundberg S. Intravenous paracetamol: the 'Stockholm protocol' for postoperative analgesia of term and preterm neonates. Pediatric Anesthesia 2007;17(11):1120-1.
10. Bauer AZ, Kriebel D. Prenatal and perinatal analgesic exposure and autism: an ecological link. Environmental Health 2013;12:1-13. [PUBMED: 10.1186/1476-069X-12-41]
11. Botting RM. Mechanism of action of acetaminophen: is there a cyclooxgygenase 3?. Clinical Infectious Diseases 2000;31 Suppl 5:S202-10.
12. Clyman R. Ibuprofen and patent ductus arteriosus. The New England Journal of Medicine 2000;343(10):728-30.
13. U.S. National Library of Medicine. Acetaminophen/Paracetamol. Drug Information Portal (druginfo.nlm.nih.gov/drugportal) 2012.
14. Edwards AD, Wyatt JS, Richardson C, Potter A, Cope M, Delpy DT, et al. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990;335(8704):1491-5.
15. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005;116(6):1353-60.
16. El-Khuffash A, Jain A, Corcoran D, Shah PS, Hooper CW, Brown N, et al. Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies. Pediatric Research 2014;76(3):238-44. [PUBMED: 24941212]
17. Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database of Systematic Reviews 2010, Issue 7. [DOI: ]
18. McMaster University, 2014. GRADEpro. [20150131]. Hamilton, Ontario, Canada: McMaster University, 2014, 2014.
19. Grèen K, Drvota V, Vesterqvist O. Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). Prostaglandins 1989;37(3):311-5.
20. Guyatt G, Oxman AD, Aklm EA, Kunz R, Vist G, Brozeka J. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383-94.
21. Hammerman C. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment. Clinics in Perinatology 1995;22(2):457-79.
22. Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 2011;128(6):e1618-21.
23. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
24. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011], The Cochrane Collaboration. Available from www.cochrane-handbook.org.
25. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Reseach Methodology 2005;20(5):13.
26. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. NICHD/NHLB/ORD Workshop summary. American Journal of Respiratory and Critical Care Medicine 2001;163:1723-9.
27. Kessel I, Waisman D, Lavie-Nevo K, Golzman M, Lorber A, Rotschild A. Paracetamol effectiveness, safety and blood level monitoring during patent ductus arteriosus closure: a case series. Journal of Maternal-Fetal & Neonatal Medicine 2014;27(16):1719-21. [PUBMED: 24460433]
28. Le J, Gales MA, Gales BJ. Acetaminophen for patent ductus arteriosus. Annals of Pharmacotherapy 2015;49(2):241-6.
29. Lee SK, McMillan DD, Ohlsson A, Pendray M, Synnes A, Whyte R, et al. Variations in practice and outcomes in the Canadian NICU network 1996-1997. Pediatrics 2000;106(5):1070-9.
30. Maisels MJ, Watchko JF. Treatment of jaundice in low birthweight infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2003;88:F459-63.
31. Mathew R. Development of the pulmonary circulation: metabolic aspects. In: Polin RA, Fox WW editor(s). Fetal and Neonatal Physiology. Vol. 1, Philadelphia: W.B. Saunders, 1998:924-9.
32. Nadir E, Kassem E, Foldi S, Hochberg A, Feldman M. Paracetamol treatment of patent ductus arteriosus in preterm infants. Journal of Perinatology 2014;34(10):748-9. [PUBMED: 24854626]
33. Naulty CM, Horn S, Conry J, Avery GB. Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease. Journal of Pediatrics 1978;93(4):682-4.
34. Ohlsson A, Bottu J, Govan J, Ryan ML, Fong K, Myhr T. Effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with patent ductus arteriosus. Developmental Pharmacology and Therapeutics 1993;20(1-2):100-6.
35. Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: ]
36. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database of Systematic Reviews 2015, Issue 2. [DOI: ; PUBMED: 23633310]
37. Palmer GM, Atkins M, Anderson BJ, Smith KR, Culnane TJ, McNally CM, et al. I.V. acetaminophen pharmacokinetics in neonates after multiple doses. British Journal of Anaesthesia 2008;101(4):523-30.
38. Peterson RG. Consequences associated with nonnarcotic analgesics in the fetus and newborn. Federation Proceedings 1985;44(7):2309-13.
39. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
40. Sakhalkar VS, Merchant RH. Therapy of symptomatic patent ductus arteriosus in preterms with mefenemic acid and indomethacin. Indian Pediatrics 1992;29(3):313-8.
41. Schünemann HJ. GRADE: From grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferabiity of the results to clinical practice [GRADE: Von der Evidenz zur Empfehlung.: Beschreibung des Systems und Lösungsbeitrag zur Übertragbarkeit von Studienergebnissen]. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 2009;103(6):391-400.
42. Seyberth HW, Rascher W, Hackenthal R, Wille L. Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus. Journal of Pediatrics 1993;103(6):979-84.
43. Simbi KA, Secchieri S, Rinaldo M, Demi M, Zanardo V. In utero ductal closure following near-term maternal self-medication with nimesulide and acetaminophen. Journal of Obstetrics and Gynaecology 2002;22(4):440-1.
44. Sinah R, Negi V, Dalal SS. An interesting observation of PDA closure with oral paracetamol in preterm neonates. Journal of Clinical Neonatology 2013;2(1):30-2. [doi: 10.4103/2249-4847.109245]
45. Sundaram SS, Alonso EM, Narkewicz MR, Zhang S, Squires RH, Pediatric Acute Liver Failure Study Group. Characterization and outcomes of young infants with acute liver failure. The Journal of Pediatrics 2011;159(5):813-8.
46. Terrin G, Conte F, Scipione A, Bacchio E, Conti MG, Ferro R. Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates. Italian Journal of Pediatrics 2014;40:21.
47. Van Loon RLE, Roofthooft MTR, Hillege HL, ten Harkel AD, Van Osch-Gevers M, Delhaas T, et al. Pediatric pulmonary hypertension in the Netherlands, Epidemiology and characterization during the period 1991 to 2005. Circulation 2011;124(16):1755-64.
48. Viberg H, Eriksson P, Gordh T, Fredriksson A. Paracetamol (acetaminophen) administration during neonatal brain development affects cognitive function and alters its analgesic and anxiolytic response in adult male mice. Toxicological Sciences 2014;138(1):139-47. [PUBMED: 24361869]
49. Walls L, Baker CF, Sarkar S. Acetaminophen-induced hepatic failure with encephalopathy in a newborn. Journal of Perinatology 2007;27(2):133-5.
50. Weir FJ, Ohlsson A, Myhr TL, Fong K, Ryan ML. A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity. European Journal of Pediatrics 1999;158(6):484-7.
51. Wilson-Smith EM, Morton NS. Survey of i.v. paracetamol (acetaminophen) use in neonates and infants under 1 year of age by UK anesthetists. Pediatric Anesthesia 2009;19(4):329-37.
52. Wolf WM, Snover DC, Leonard AS. Localized intestinal perforation following intravenous indomethacin in premature infants. Journal of Pediatric Surgery 1989;24(4):409-10.
53. Yurttutan S, Oncel MY, Arayici S, Uras N, Altug N, Erdeve O, et al. A different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol. Journal of Maternal-Fetal & Neonatal Medicine 2013;26(8):825-7. [DOI: ]